Having vaccinated more people against COVID-19 per capita than any other country, Israel is in a unique position to study the effects of the first of two doses of the Pfizer/BioNTech vaccine. Clalit, Israel’s largest health maintenance organization (HMO), looked at COVID-19 test results of 200,000